Appropriate use of echocardiography in managing Staphylococcus aureus bacteremia

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 4, 2012, Pages 501-508

  Palraj, Bharath Raj ^a   Sohail, Muhammad R ^a  

^a Mayo Clinic   (United States)

Author keywords

bacteremia; bloodstream infection; endocarditis; infection; management; Staphylococcus aureus; transesophageal echocardiogram

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC RESISTANCE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EPIDEMIOLOGY; HEART VALVE PROSTHESIS; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INFECTIOUS DISEASE MEDICINE; INTRAVENOUS DRUG ABUSE; MEDICAL SPECIALIST; PATIENT ASSESSMENT; PATIENT REFERRAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STAPHYLOCOCCAL BACTEREMIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION;

ALGORITHMS; BACTEREMIA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84860110181     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.22     Document Type: Review

References (52)

1. Wisplinghoff H, Bischoff T, Talent SM et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39(3), 309-317 (2004). (Pubitemid 39050477)
2. Abraham J, Mansour C, Veledar E et al. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Am. Heart. J. 147(3), 536-539 (2004). (Pubitemid 38880879)
3. Jensen AG, Wachmann C, Poulsen KB et al. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch. Intern. Med. 159(13), 1437-1444 (1999). (Pubitemid 29302884)
4. Benito N, Miro J, Lazzari E et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann. Intern. Med. 150(9), 586-594 (2009).
5. Petti CA, Fowler VG Jr. Staphylococcus aureus bacteremia and endocarditis. Cardiol. Clin. 21(2), 219-233 (2003).
6. Roder BL, Wandall DA, Frimodt-Moller N et al. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch. Intern. Med. 159(5), 462-469 (1999). (Pubitemid 29108911)
7. Miro JM, Anguera I, Cabell CH et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin. Infect. Dis. 41(4), 507-514 (2005). (Pubitemid 41099645)
8. Wilson R, Hamburger M. Fifteen years' experience with staphylococcus septicemia in a large city hospitals; analyis of ffty-five cases in the Cincinnati general Hospital 1940 to 1954. Am. J. Med. 22(3), 437-457 (1957).
9. Fowler VG Jr, Li J, Corey R et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J. Am. Coll. Cardiol. 30(4), 1072-1078 (1997). (Pubitemid 27435904)
10. Fowler VG Jr, Sanders LL, Sexton DJ et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin. Infect. Dis. 27(3), 478-486 (1998). (Pubitemid 28421994)
11. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev. Infect. Dis. 9(5), 891-907 (1987).
12. Chang FY, MacDonald BB, Peacock JE Jr. et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82(5), 322-332 (2003). (Pubitemid 37229467)
13. Hill EE, Vanderschueren S, Verhaegen J et al. Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia. Mayo Clin. Proc. 82(10), 1165-1169 (2007). (Pubitemid 47502873)
14. Fowler VG Jr, Olsen MK, Corey GR et al. Clinical identifers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 163(17), 2066-2072 (2003). (Pubitemid 37151249)
15. Nolan CM, Beaty HN. Staphylococcus aureus bacteraemia. Current clinical patterns. Am. J. Med. 60, 495-500 (1976).
16. Fowler VG Jr, Sakoulas G, McIntyre LM et al. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190(6), 1140-1149 (2004). (Pubitemid 39186802)
17. Xiong YQ, Fowler VG, Yeaman MR et al. Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. J. Infect. Dis. 199(2), 201-208 (2009).
18. Fowler VG Jr, Nelson CL, McIntyre LM et al. Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J. Infect. Dis. 196(5), 738-747 (2007). (Pubitemid 47293857)
19. Lalani T, Chu VH, Grussemeyer CA et al. Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. Scand. J. Infect. Dis. 40(11-12), 973-977 (2008)
20. Willcox. Community-acquired Staphylococcus aureus bacteremia in patients who do not abuse intravenous drugs. Q. J. Med. 91, 41-47 (1998).
21. Fowler VG Jr, Justice A, Moore C et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin. Infect. Dis. 40(5), 695-703 (2005). (Pubitemid 40381343)
22. El-Ahdab F, Benjamin DK Jr, Wang A et al. Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am. J. Med. 118(3), 225-229 (2005). (Pubitemid 40312632)
23. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev. Infect. Dis. 9(5), 891-907 (1987).
24. Chang FY, MacDonald BB, Peacock JE Jr et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82(5), 322-332 (2003). (Pubitemid 37229467)
25. Uslan DZ, Dowsley TF, Sohail MR et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin. Electrophysiol. 33(4), 407-413 (2010).
26. Erbel R, Rohmann S, Drexler M et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur. Heart J. 9(1), 43-53 (1988).
27. Reynolds HR, Jagen MA, Tunick PA, Kronzon I. Sensitivity of transthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J. Am. Soc. Echocardiogr. 16(1), 67-70 (2003). (Pubitemid 36522818)
28. Jacob S, Tong AT. Role of echocardiography in the diagnosis and management of infective endocarditis. Curr. Opin. Cardiol 17(5), 478-485 (2002). (Pubitemid 35265784)
29. Daniel WG, Mugge A, Grote J et al Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am. J. Cardiol. 71(2), 210-215 (1993). (Pubitemid 23030646)
30. Daniel WG, Mugge A, Martin RP et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N. Engl J. Med. 324(12), 795-800 (1991).
31. De Castro S, Cartoni D, d'Amati G et al Diagnostic accuracy of transthoracic and multiplane transesophageal echocardiography for valvular perforation in acute infective endocarditis: correlation with anatomic fndings. Clin. Infect. Dis. 30(5), 825-826 (2000).
32. Daniel WG, Erbel R, Kasper W et al. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation 83(3), 817-821 (1991).
33. Kaasch AJ, Fowler VG Jr, Rieg S et al Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin. Infect. Dis. 53(1), 1-9 (2011).
34. Rosen AB, Fowler VG Jr, Corey GR et al Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann. Intern. Med. 130(10), 810-820 (1999). (Pubitemid 29231149)
35. Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46(7), 1000-1008 (2008). (Pubitemid 351589864)
36. Khatib R, Johnson LB, Fakih MG et al. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand. J. Infect. Dis. 38(1), 7-14 (2006). (Pubitemid 43123837)
37. Lesens O, Hansmann Y, Storck D, Christmann D. Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. Eur. J. Intern. Med. 14(4), 227-231 (2003). (Pubitemid 36952700)
38. Rasmussen RV, Host U, Arpi M et al Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur. J. Echocardiogr. 12(6), 414-420 (2011).
39. Sochowski RA, Chan KL. Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. J. Am. Coll. Cardiol. 21(1), 216-221 (1993). (Pubitemid 23031318)
40. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49(1), 1-45 (2009).
41. Cosgrove SE, Fowler VG Jr. Management of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46(Suppl. 5), S386-S393 (2008). (Pubitemid 351717326)
42. Baddour LM, Epstein AE, Erickson CC et al. Update on cardiovascular implantable electronic device infections and their management: a scientifc statement from the American Heart Association. Circulation 121(3), 458-477 (2010).
43. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111 (23), e394-e434 (2005).
44. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N. Engl. J. Med. 345(18), 1318-1330 (2001).
45. Bayer AS, Lam K, Ginzton L, Norman DC, Chiu CY, Ward JI. Staphylococcus aureus bacteremia. Clinical, serologic, and echocardiographic fndings in patients with and without endocarditis. Arch. Intern. Med. 147(3), 457-462 (1987). (Pubitemid 17036583)
46. Gopal AK, Fowler VG Jr, Shah M et al. Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J. Clin. Oncol. 18(5), 1110-1115 (2000). (Pubitemid 30123790)
47. Cabell CH, Fowler VG Jr. Importance of aggressive evaluation in patients with Staphylococcus aureus bacteremia. Am. Heart J. 147(3), 379-380 (2004). (Pubitemid 38880851)
48. Cabell CH, Fowler VG Jr. Repeated echocardiography after the diagnosis of endocarditis: too much of a good thing? Heart, 90(9), 975-976 (2004). (Pubitemid 39127900)
49. Chamis AL, Gesty-Palmer D, Fowler VG, Corey GR. Echocardiography for the diagnosis of Staphylococcus aureus infective endocarditis. Curr. Infect. Dis. Rep. 1(2), 129-135 (1999).
50. Chamis AL, Peterson GE, Cabell CH et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter- defbrillators. Circulation 104 (9), 1029-1033 (2001). (Pubitemid 32803880)
51. Sullenberger AL, Avedissian LS, Kent SM. Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia. J. Heart Valve Dis. 14(1), 23-28 (2005). (Pubitemid 47050764)
52. Van Hal SJ, Mathur G, Kelly J, Aronis C, Cranney GB, Jones PD. The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia. J. Infect. 51(3), 218-221 (2005). (Pubitemid 41554830)